IPT and Efficacy of Sulphadoxine/Pyrimethamine and Chlorproguanil/Dapsone in 6-59 Month Old Children With Malaria.

This study has been terminated.

(SP arms were stopped due to high levels of treatment failure.CD not available.)

Sponsor:

Information provided by:

Gates Malaria Partnership

ClinicalTrials.gov Identifier:

NCT00361114

First received: August 3, 2006

Last updated: May 1, 2008

Last verified: May 2008

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been terminated.
Study Completion Date:	October 2007
Primary Completion Date:	August 2007 (Final data collection date for primary outcome measure)

No publications provided by Gates Malaria Partnership

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Gesase S, Gosling RD, Hashim R, Ord R, Naidoo I, Madebe R, Mosha JF, Joho A, Mandia V, Mrema H, Mapunda E, Savael Z, Lemnge M, Mosha FW, Greenwood B, Roper C, Chandramohan D. High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. PLoS ONE. 2009;4(2):e4569. Epub 2009 Feb 24.

To Top